Pfizer (PFE) Change in Acquisitions & Divestments (2010 - 2026)

Pfizer (PFE) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 68.86% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $14.1 billion, a 0.78% decrease from a year earlier, with the FY2025 full-year figure at $18.0 billion, up 335.05% from the prior year.
• Change in Acquisitions & Divestments was $2.0 billion for Q2 2026 at Pfizer, down from $4.6 billion in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $21.2 billion in Q4 2023 and troughed at $658.0 million in Q1 2024.
• A 5-year average of $5.9 billion and a median of $4.6 billion in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments plunged 89.72% in 2024 and soared 520.97% in 2025, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $6.7 billion in 2022, then surged by 215.69% to $21.2 billion in 2023, then tumbled by 87.62% to $2.6 billion in 2024, then soared by 79.58% to $4.7 billion in 2025, then sank by 56.85% to $2.0 billion in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $2.0 billion (Q2 2026), $4.6 billion (Q1 2026), and $4.7 billion (Q4 2025), per Business Quant data.